Vikash Sharma

Stressing that consumption of medicines without medical supervision can lead to severe health complications, the Central Consumer Protection Authority (CCPA) has issued an advisory to e-commerce entities regarding the sale of Ayurvedic, Siddha and Unani drugs.

The advisory has been issued for ayurvedic, siddha and unani drugs containing ingredients listed in Schedule E (1) of the Drugs and Cosmetics Rules, 1945.

The E-commerce platforms have been advised that the sale or facilitating the sale of such drugs shall be done only after a valid prescription of a registered Ayurveda, Siddha or Unani practitioner respectively is uploaded by the user on the platform.


Rule 161(2) of the Drugs and Cosmetics Rules, 1945

The container of a medicine for internal use for the treatment of human ailments shall, if it is made up of a substance specified in Schedule E (1), be labelled conspicuously with the words “Caution: To be taken under medical supervision” both in English and Hindi language.

As per a PIB release, the Ministry of Ayush had issued a public notice on 01.02.2016 informing stakeholders that the aforementioned drugs are required to be taken under Medical Supervision and purchasing the same online should be avoided without medical consultation.